Interventions for noisy breathing in patients near to death

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Wee, Bee ^a   Hillier, R ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; PLACEBO; SCOPOLAMINE; SCOPOLAMINE BROMIDE; SCOPOLAMINE BUTYL BROMIDE;

BREATHING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEATH; HUMAN; INTERVENTION STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

EID: 44949197754     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005177.pub2     Document Type: Review

References (37)

1. Likar 2002 {published data only} Likar R, Molnar M, Rupacher E, Pipam W, Deutsch J, Mortl M, et al.A clinical study examining the efficacy of scopolamin-hydrobromide in patients with death rattle (a randomised double-blind, placebo-controlled study) [Klinische untersuchung uber die wirkung von scopolamin-hydrobromicum beim terminalen rasseln (randomisierte, doppelblind, plazebokontrollierte studie)]. Z Palliativmed 2002;3:15-9.
2. Back 2001 Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliative Medicine 2001;15:329-36.
3. Bennett 1996 Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. PalliativeMedicine 1996;12(4):229-33.
4. Bennett 2002 Bennett M, Lucas V, Brennan M, Hughes A, O'Donnell V, Wee B. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliative Medicine 2002;16:369-74.
5. Dawson 1989 Dawson HR. The use of transdermal scopolamine in the control of death rattle. Journal of Palliative Care 1989;5(1):31- 3.
6. Ellershaw 2001 Ellershaw JE, Smith C, Overill S, Walker SE, Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. Journal of Pain and Symptom Management 2001;21(1):12-7.
7. Elman 2005 Elman LB, Dubin RM, Kelley M, McCluskey L. Management of oropharyngeal and tracheobronchial secretions in patients with neurologic disease. Journal of Palliative Medicine 2005;8(6):1150-9.
8. Fainsinger 1999 Fainsinger RL. Biochemical dehydration in terminally ill cancer patients. Journal of Palliative Care 1999; Vol. 15, issue 2:59-61.
9. Hall 2002 Hall P, Weaver L. The last 48 hours of life in long-term care: a focused chart audit. Journal of American Geriatric Society 2002;50:501-6.
10. Hugel 2006 Hugel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. Journal of Palliative Medicine 2006;9(2):279-84.
11. Hughes 1996 Hughes AC, Wilcock A, Corcoran R. Management of "death rattle". Journal of Pain and Symptom Management 1996; Vol. 12, issue 5: 271-2.
12. Hughes 1997 Hughes A, Wilcock A, Corcoran R. Management of 'death rattle'. Palliative Medicine. 1997; Vol. 11, issue 1:80-1.
13. Hughes 2000 Hughes A, Wilcock A, Corcoran R, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliative Medicine 2000;14:221-2.
14. Kass 2003 Kass RM, Ellershaw J. Respiratory tract secretions in the dying patient: a retrospective study. Journal of Pain and Symptom Management 2003;26(4):897-902.
15. Kompanje 2005 Kompanje JO. "The death rattle" in the intensive care unit after withdrawal of mechanical ventilation in neurological patients. Neurocritical Care 2005;3:107-10.
16. Kompanje 2006 Kompanje EJO. 'Death rattle' after withdrawal of mechanical ventilation: practical and ethical considerations. Intensive and Critical Care Nursing 2006;22:214-9.
17. Lucas 1994 Lucas V, Burrage H, Mistry A. The use of glycopyrrolate by syringe driver to alleviate bronchial secretions. Progress in Palliative Care 1994; Vol. 2, issue 1:11.
18. Macleod 2002 Macleod AD. Neurogenic pulmonary oedema in palliative care. Journal of Pain and Symptom Management 2002;23(2):154-6.
19. Morita 2000 Morita T, Tsunoda J, Inoue S, Chihara S. Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study. Palliative Medicine 2000;14:19-23.
20. Morita 2004 Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, et al.Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. Journal of Pain and Symptom Management 2004;26(6):533-9.
21. Murtagh 2002 Murtagh FEM, Thorns A, Oliver DJ. Hyoscine and glycopyrrolate for death rattle. Palliative Medicine 2002; Vol. 16:449-50.
22. O'Donnell 1998 O'Donnell V. The pharmacological management of respiratory tract secretions. International Journal of Palliative Nursing 1998;4(4):199-203.
23. Sorensen 2000 Sorensen HM. Managing secretions in dying patients. Respiratory Care 2000;45(11):1355-62.
24. Spiess 2003 Spiess JL, Scott SD. Anticholinergic agents for the treatment of "death rattle" in patients with myasthenia gravis. Journal of Pain and Symptom Management 2003;26:684-6.
25. Spiller 2000 Spiller JA, Fallon M. The use of scopodermin palliative care.Hospital Medicine 2000;61(11):782-4.
26. Spruyt 1998 Spruyt O, Kausae A. Antibiotic use for infective terminal respiratory secretions. Journal of Pain and Symptom Management 1998;15(5):263-4.
27. Stone 2001 Stone P, Rees E, Hardy JR. End of life care in patients with malignant disease. European Journal of Cancer 2001;37:1070- 5.
28. Watts 1997 Watts T, Jenkins K, Back I. Problem and management of noisy rattling breathing in dying patients. International Journal of Palliative Nursing 1997;3(5):245-52.
29. Wildiers 2002 Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. Journal of Pain and Symptom Management 2002;23(4):310-7.
30. Wildiers 2007 Multicentre prospective randomised trial. Ongoing study 2001.
31. Ahmedzai 1998 Ahmedzai S. Palliation of respiratory symptoms. In: DoyleD, HanksGWC, MacDonaldN editor(s). Oxford Textbook of Palliative Medicine. second. Oxford: Oxford University Press, 1998:583-616.
32. Ellershaw 1995 Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. Journal of Pain and Symptom Management 1995;10(3):192-7.
33. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
34. Lichter 1990 Lichter I, Hunt E. The last 48 hours of life. Journal of Palliative Care 1990;6(4):7-15.
35. Twycross 1998 Twycross R, Lichter I. The terminal phase. In: DoyleD, HanksGWC, MacDonaldN editor(s). Oxford Textbook of Palliative Medicine. second. Oxford: Oxford University Press, 1998:977-92.
36. Wee 2006 Wee B, Coleman P, Hillier R, Holgate S. The sound of death rattle II: how do relatives interpret the sound?. Palliative Medicine 2006;20(3):177-81.
37. Wiffen 2005 Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD001133. DOI: 10.1002/14651858.CD001133.pub2.